Welcome to BusinessBankruptcies.com!

Sign up for a free account to get access to data on case creditors, search for cases, and more.

Aralez Pharmaceuticals Trading Designated Activity

COURT
New York Southern Bankruptcy Court
CASE NUMBER
1:2018bk12429
TYPE / CHAPTER
Voluntary / 11

Subscribe to This Case

Follow this case and receive case update emails for the life of this case for a one-time fee of $39.95.

Case Information

This case has a LEAD CASE: Aralez Pharmaceuticals US Inc.

When following such a bankruptcy, it is important to follow the lead case. When we detect a group of jointly administered cases, we mark the associated and lead cases. The case information tab of the case page will show whether a case is associated with a lead case, or is a lead case and has associated cases.

Filed

8-10-18

Updated

9-13-23

Last Checked

8-13-18

Assets

Subscribe

Liabilities

Subscribe

Get notified when your customers file for bankruptcy

Docket

Last Updated
Aug 13, 2018
Last Entry Filed
Aug 10, 2018

Docket Entries by Quarter

Aug 10, 2018 1 Petition Chapter 11 Voluntary Petition for Non-Individual. Order for Relief Entered. Filed by Paul V. Shalhoub of Willkie Farr & Gallagher LLP on behalf of Aralez Pharmaceuticals Trading Designated Activity Company. (Shalhoub, Paul) (Entered: 08/10/2018)
Aug 10, 2018 Receipt of Voluntary Petition (Chapter 11)(18-12429) [misc,824] (1717.00) Filing Fee. Receipt number 12714853. Fee amount 1717.00. (Re: Doc # 1) (U.S. Treasury) (Entered: 08/10/2018)
Aug 10, 2018 2 Motion for Joint Administration / Debtors' Motion for Order Authorizing Joint Administration Pursuant to Rule 1015(b) of the Federal Rules of Bankruptcy Procedure filed by Robin Spigel on behalf of Aralez Pharmaceuticals Trading Designated Activity Company. (Spigel, Robin) (Entered: 08/10/2018)
Aug 10, 2018 3 Motion to Extend Deadline to File Schedules or Provide Required Information / Debtors' Motion for Order Extending Deadline for Debtors to File their Schedules of Assets and Liabilities and Statements of Financial Affairs filed by Robin Spigel on behalf of Aralez Pharmaceuticals Trading Designated Activity Company. (Spigel, Robin) (Entered: 08/10/2018)
Aug 10, 2018 4 Declaration of Michael Kaseta in Support of Chapter 11 Petitions and First Day Pleadings filed by Robin Spigel on behalf of Aralez Pharmaceuticals Trading Designated Activity Company. (Spigel, Robin) (Entered: 08/10/2018)
Aug 10, 2018 Judge Martin Glenn added to the case. (Porter, Minnie). (Entered: 08/10/2018)

This case is closed and is no longer being updated.

Case Information

Court
New York Southern Bankruptcy Court
Case number
1:2018bk12429
Assets
Subscribe for Access
Liabilities
Subscribe for Access
Judge
Martin Glenn
Chapter
11
Filed
Aug 10, 2018
Type
voluntary
Terminated
Jun 28, 2019
Updated
Sep 13, 2023
Last checked
Aug 13, 2018
Lead case
Aralez Pharmaceuticals US Inc.

Associated Cases

    This case has no creditors listed.

    Parties

    Debtor

    Aralez Pharmaceuticals Trading Designated Activity Company
    2 Hume Street
    Fourth Floor
    Dublin 2 D02 FT82
    OUTSIDE U. S.
    Ireland
    Tax ID / EIN: xx-xxx1627
    fka Pozen Limited
    fka Aralez Pharmaceuticals Trading Limited

    Represented By

    Paul V. Shalhoub
    Willkie Farr & Gallagher LLP
    787 Seventh Avenue
    New York, NY 10019-6099
    (212) 728-8764
    Fax : (212) 728-8111
    Email: maosbny@willkie.com
    Robin Spigel
    Willkie Far & Gallagher LLP
    787 Seventh Avenue
    New York, NY 10019-6099
    212 728-8822
    Fax : 212 728-8111
    Email: maosbny@willkie.com

    U.S. Trustee

    United States Trustee
    Office of the United States Trustee
    U.S. Federal Office Building
    201 Varick Street, Room 1006
    New York, NY 10014
    (212) 510-0500